Industry Research Reports

Home > Reports > Service & Software > Global Pharma Contract Service Market Research Report 2025

Global Pharma Contract Service Market Research Report 2025

Industry: Service & Software

Published Date: 2025-02-04

Pages: 90 Pages

Report ld: 3651491

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Pharma Contract Service Market Size(US$)

CAGR 2025-2031

7.3%

Market Size,2031

USD 246,380

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 161,440 million

Market Forecast in 2031(Value)

US$ 246,380 million

CAGR

7.3%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Pharma Contract Service was valued at US$ 151490 million in the year 2024 and is projected to reach a revised size of US$ 246380 million by 2031, growing at a CAGR of 7.3% during the forecast period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Pharma Contract Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharma Contract Service.

The Pharma Contract Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharma Contract Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pharma Contract Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

MARKET SEGMENTATION

By Company

ICON PLC
IQVIA
PPD
Eurofins Scientific
WuXi AppTec
Labcorp Drug Development
Syneos Health
Parexel
Medpace
Charles River
Lonza
Aldevron
Catalent

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Contract Research Organization (CRO)
Contract Development and Manufacruring Organization (CDMO)
Contract Manufacturing Organization (CMO)

Segment by Application

Pharmaceutical Company
Biotechnology Company
Generic Company

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pharma Contract Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pharma Contract Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Contract Research Organization (CRO)

1.2.3 Contract Development and Manufacruring Organization (CDMO)

1.2.4 Contract Manufacturing Organization (CMO)

1.3 Market by Application

1.3.1 Global Pharma Contract Service Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical Company

1.3.3 Biotechnology Company

1.3.4 Generic Company

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Pharma Contract Service Market Perspective (2020-2031)

2.2 Global Pharma Contract Service Growth Trends by Region

2.2.1 Global Pharma Contract Service Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Pharma Contract Service Historic Market Size by Region (2020-2025)

2.2.3 Pharma Contract Service Forecasted Market Size by Region (2026-2031)

2.3 Pharma Contract Service Market Dynamics

2.3.1 Pharma Contract Service Industry Trends

2.3.2 Pharma Contract Service Market Drivers

2.3.3 Pharma Contract Service Market Challenges

2.3.4 Pharma Contract Service Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Pharma Contract Service Players by Revenue

3.1.1 Global Top Pharma Contract Service Players by Revenue (2020-2025)

3.1.2 Global Pharma Contract Service Revenue Market Share by Players (2020-2025)

3.2 Global Pharma Contract Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Pharma Contract Service Revenue

3.4 Global Pharma Contract Service Market Concentration Ratio

3.4.1 Global Pharma Contract Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pharma Contract Service Revenue in 2024

3.5 Global Key Players of Pharma Contract Service Head office and Area Served

3.6 Global Key Players of Pharma Contract Service, Product and Application

3.7 Global Key Players of Pharma Contract Service, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Pharma Contract Service Breakdown Data by Type

4.1 Global Pharma Contract Service Historic Market Size by Type (2020-2025)

4.2 Global Pharma Contract Service Forecasted Market Size by Type (2026-2031)

5 Pharma Contract Service Breakdown Data by Application

5.1 Global Pharma Contract Service Historic Market Size by Application (2020-2025)

5.2 Global Pharma Contract Service Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Pharma Contract Service Market Size (2020-2031)

6.2 North America Pharma Contract Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Pharma Contract Service Market Size by Country (2020-2025)

6.4 North America Pharma Contract Service Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Pharma Contract Service Market Size (2020-2031)

7.2 Europe Pharma Contract Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Pharma Contract Service Market Size by Country (2020-2025)

7.4 Europe Pharma Contract Service Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Pharma Contract Service Market Size (2020-2031)

8.2 Asia-Pacific Pharma Contract Service Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Pharma Contract Service Market Size by Region (2020-2025)

8.4 Asia-Pacific Pharma Contract Service Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Pharma Contract Service Market Size (2020-2031)

9.2 Latin America Pharma Contract Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Pharma Contract Service Market Size by Country (2020-2025)

9.4 Latin America Pharma Contract Service Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Pharma Contract Service Market Size (2020-2031)

10.2 Middle East & Africa Pharma Contract Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Pharma Contract Service Market Size by Country (2020-2025)

10.4 Middle East & Africa Pharma Contract Service Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 ICON PLC

11.1.1 ICON PLC Company Details

11.1.2 ICON PLC Business Overview

11.1.3 ICON PLC Pharma Contract Service Introduction

11.1.4 ICON PLC Revenue in Pharma Contract Service Business (2020-2025)

11.1.5 ICON PLC Recent Development

11.2 IQVIA

11.2.1 IQVIA Company Details

11.2.2 IQVIA Business Overview

11.2.3 IQVIA Pharma Contract Service Introduction

11.2.4 IQVIA Revenue in Pharma Contract Service Business (2020-2025)

11.2.5 IQVIA Recent Development

11.3 PPD

11.3.1 PPD Company Details

11.3.2 PPD Business Overview

11.3.3 PPD Pharma Contract Service Introduction

11.3.4 PPD Revenue in Pharma Contract Service Business (2020-2025)

11.3.5 PPD Recent Development

11.4 Eurofins Scientific

11.4.1 Eurofins Scientific Company Details

11.4.2 Eurofins Scientific Business Overview

11.4.3 Eurofins Scientific Pharma Contract Service Introduction

11.4.4 Eurofins Scientific Revenue in Pharma Contract Service Business (2020-2025)

11.4.5 Eurofins Scientific Recent Development

11.5 WuXi AppTec

11.5.1 WuXi AppTec Company Details

11.5.2 WuXi AppTec Business Overview

11.5.3 WuXi AppTec Pharma Contract Service Introduction

11.5.4 WuXi AppTec Revenue in Pharma Contract Service Business (2020-2025)

11.5.5 WuXi AppTec Recent Development

11.6 Labcorp Drug Development

11.6.1 Labcorp Drug Development Company Details

11.6.2 Labcorp Drug Development Business Overview

11.6.3 Labcorp Drug Development Pharma Contract Service Introduction

11.6.4 Labcorp Drug Development Revenue in Pharma Contract Service Business (2020-2025)

11.6.5 Labcorp Drug Development Recent Development

11.7 Syneos Health

11.7.1 Syneos Health Company Details

11.7.2 Syneos Health Business Overview

11.7.3 Syneos Health Pharma Contract Service Introduction

11.7.4 Syneos Health Revenue in Pharma Contract Service Business (2020-2025)

11.7.5 Syneos Health Recent Development

11.8 Parexel

11.8.1 Parexel Company Details

11.8.2 Parexel Business Overview

11.8.3 Parexel Pharma Contract Service Introduction

11.8.4 Parexel Revenue in Pharma Contract Service Business (2020-2025)

11.8.5 Parexel Recent Development

11.9 Medpace

11.9.1 Medpace Company Details

11.9.2 Medpace Business Overview

11.9.3 Medpace Pharma Contract Service Introduction

11.9.4 Medpace Revenue in Pharma Contract Service Business (2020-2025)

11.9.5 Medpace Recent Development

11.10 Charles River

11.10.1 Charles River Company Details

11.10.2 Charles River Business Overview

11.10.3 Charles River Pharma Contract Service Introduction

11.10.4 Charles River Revenue in Pharma Contract Service Business (2020-2025)

11.10.5 Charles River Recent Development

11.11 Lonza

11.11.1 Lonza Company Details

11.11.2 Lonza Business Overview

11.11.3 Lonza Pharma Contract Service Introduction

11.11.4 Lonza Revenue in Pharma Contract Service Business (2020-2025)

11.11.5 Lonza Recent Development

11.12 Aldevron

11.12.1 Aldevron Company Details

11.12.2 Aldevron Business Overview

11.12.3 Aldevron Pharma Contract Service Introduction

11.12.4 Aldevron Revenue in Pharma Contract Service Business (2020-2025)

11.12.5 Aldevron Recent Development

11.13 Catalent

11.13.1 Catalent Company Details

11.13.2 Catalent Business Overview

11.13.3 Catalent Pharma Contract Service Introduction

11.13.4 Catalent Revenue in Pharma Contract Service Business (2020-2025)

11.13.5 Catalent Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Pharma Contract Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Contract Research Organization (CRO)

Table 3. Key Players of Contract Development and Manufacruring Organization (CDMO)

Table 4. Key Players of Contract Manufacturing Organization (CMO)

Table 5. Global Pharma Contract Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Pharma Contract Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Pharma Contract Service Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Pharma Contract Service Market Share by Region (2020-2025)

Table 9. Global Pharma Contract Service Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Pharma Contract Service Market Share by Region (2026-2031)

Table 11. Pharma Contract Service Market Trends

Table 12. Pharma Contract Service Market Drivers

Table 13. Pharma Contract Service Market Challenges

Table 14. Pharma Contract Service Market Restraints

Table 15. Global Pharma Contract Service Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Pharma Contract Service Market Share by Players (2020-2025)

Table 17. Global Top Pharma Contract Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma Contract Service as of 2024)

Table 18. Ranking of Global Top Pharma Contract Service Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Pharma Contract Service Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Pharma Contract Service, Headquarters and Area Served

Table 21. Global Key Players of Pharma Contract Service, Product and Application

Table 22. Global Key Players of Pharma Contract Service, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Pharma Contract Service Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Pharma Contract Service Revenue Market Share by Type (2020-2025)

Table 26. Global Pharma Contract Service Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Pharma Contract Service Revenue Market Share by Type (2026-2031)

Table 28. Global Pharma Contract Service Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Pharma Contract Service Revenue Market Share by Application (2020-2025)

Table 30. Global Pharma Contract Service Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Pharma Contract Service Revenue Market Share by Application (2026-2031)

Table 32. North America Pharma Contract Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Pharma Contract Service Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Pharma Contract Service Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Pharma Contract Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Pharma Contract Service Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Pharma Contract Service Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Pharma Contract Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Pharma Contract Service Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Pharma Contract Service Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Pharma Contract Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Pharma Contract Service Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Pharma Contract Service Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Pharma Contract Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Pharma Contract Service Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Pharma Contract Service Market Size by Country (2026-2031) & (US$ Million)

Table 47. ICON PLC Company Details

Table 48. ICON PLC Business Overview

Table 49. ICON PLC Pharma Contract Service Product

Table 50. ICON PLC Revenue in Pharma Contract Service Business (2020-2025) & (US$ Million)

Table 51. ICON PLC Recent Development

Table 52. IQVIA Company Details

Table 53. IQVIA Business Overview

Table 54. IQVIA Pharma Contract Service Product

Table 55. IQVIA Revenue in Pharma Contract Service Business (2020-2025) & (US$ Million)

Table 56. IQVIA Recent Development

Table 57. PPD Company Details

Table 58. PPD Business Overview

Table 59. PPD Pharma Contract Service Product

Table 60. PPD Revenue in Pharma Contract Service Business (2020-2025) & (US$ Million)

Table 61. PPD Recent Development

Table 62. Eurofins Scientific Company Details

Table 63. Eurofins Scientific Business Overview

Table 64. Eurofins Scientific Pharma Contract Service Product

Table 65. Eurofins Scientific Revenue in Pharma Contract Service Business (2020-2025) & (US$ Million)

Table 66. Eurofins Scientific Recent Development

Table 67. WuXi AppTec Company Details

Table 68. WuXi AppTec Business Overview

Table 69. WuXi AppTec Pharma Contract Service Product

Table 70. WuXi AppTec Revenue in Pharma Contract Service Business (2020-2025) & (US$ Million)

Table 71. WuXi AppTec Recent Development

Table 72. Labcorp Drug Development Company Details

Table 73. Labcorp Drug Development Business Overview

Table 74. Labcorp Drug Development Pharma Contract Service Product

Table 75. Labcorp Drug Development Revenue in Pharma Contract Service Business (2020-2025) & (US$ Million)

Table 76. Labcorp Drug Development Recent Development

Table 77. Syneos Health Company Details

Table 78. Syneos Health Business Overview

Table 79. Syneos Health Pharma Contract Service Product

Table 80. Syneos Health Revenue in Pharma Contract Service Business (2020-2025) & (US$ Million)

Table 81. Syneos Health Recent Development

Table 82. Parexel Company Details

Table 83. Parexel Business Overview

Table 84. Parexel Pharma Contract Service Product

Table 85. Parexel Revenue in Pharma Contract Service Business (2020-2025) & (US$ Million)

Table 86. Parexel Recent Development

Table 87. Medpace Company Details

Table 88. Medpace Business Overview

Table 89. Medpace Pharma Contract Service Product

Table 90. Medpace Revenue in Pharma Contract Service Business (2020-2025) & (US$ Million)

Table 91. Medpace Recent Development

Table 92. Charles River Company Details

Table 93. Charles River Business Overview

Table 94. Charles River Pharma Contract Service Product

Table 95. Charles River Revenue in Pharma Contract Service Business (2020-2025) & (US$ Million)

Table 96. Charles River Recent Development

Table 97. Lonza Company Details

Table 98. Lonza Business Overview

Table 99. Lonza Pharma Contract Service Product

Table 100. Lonza Revenue in Pharma Contract Service Business (2020-2025) & (US$ Million)

Table 101. Lonza Recent Development

Table 102. Aldevron Company Details

Table 103. Aldevron Business Overview

Table 104. Aldevron Pharma Contract Service Product

Table 105. Aldevron Revenue in Pharma Contract Service Business (2020-2025) & (US$ Million)

Table 106. Aldevron Recent Development

Table 107. Catalent Company Details

Table 108. Catalent Business Overview

Table 109. Catalent Pharma Contract Service Product

Table 110. Catalent Revenue in Pharma Contract Service Business (2020-2025) & (US$ Million)

Table 111. Catalent Recent Development

Table 112. Research Programs/Design for This Report

Table 113. Key Data Information from Secondary Sources

Table 114. Key Data Information from Primary Sources

Table 115. Authors List of This Report

List of Figures

Figure 1. Pharma Contract Service Picture

Figure 2. Global Pharma Contract Service Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Pharma Contract Service Market Share by Type: 2024 VS 2031

Figure 4. Contract Research Organization (CRO) Features

Figure 5. Contract Development and Manufacruring Organization (CDMO) Features

Figure 6. Contract Manufacturing Organization (CMO) Features

Figure 7. Global Pharma Contract Service Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Pharma Contract Service Market Share by Application: 2024 VS 2031

Figure 9. Pharmaceutical Company Case Studies

Figure 10. Biotechnology Company Case Studies

Figure 11. Generic Company Case Studies

Figure 12. Pharma Contract Service Report Years Considered

Figure 13. Global Pharma Contract Service Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Pharma Contract Service Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Pharma Contract Service Market Share by Region: 2024 VS 2031

Figure 16. Global Pharma Contract Service Market Share by Players in 2024

Figure 17. Global Top Pharma Contract Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma Contract Service as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Pharma Contract Service Revenue in 2024

Figure 19. North America Pharma Contract Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Pharma Contract Service Market Share by Country (2020-2031)

Figure 21. United States Pharma Contract Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Pharma Contract Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Pharma Contract Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Pharma Contract Service Market Share by Country (2020-2031)

Figure 25. Germany Pharma Contract Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Pharma Contract Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Pharma Contract Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Pharma Contract Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Pharma Contract Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Pharma Contract Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Pharma Contract Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Pharma Contract Service Market Share by Region (2020-2031)

Figure 33. China Pharma Contract Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Pharma Contract Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Pharma Contract Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Pharma Contract Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Pharma Contract Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Pharma Contract Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Pharma Contract Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Pharma Contract Service Market Share by Country (2020-2031)

Figure 41. Mexico Pharma Contract Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Pharma Contract Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Pharma Contract Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Pharma Contract Service Market Share by Country (2020-2031)

Figure 45. Turkey Pharma Contract Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Pharma Contract Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Pharma Contract Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. ICON PLC Revenue Growth Rate in Pharma Contract Service Business (2020-2025)

Figure 49. IQVIA Revenue Growth Rate in Pharma Contract Service Business (2020-2025)

Figure 50. PPD Revenue Growth Rate in Pharma Contract Service Business (2020-2025)

Figure 51. Eurofins Scientific Revenue Growth Rate in Pharma Contract Service Business (2020-2025)

Figure 52. WuXi AppTec Revenue Growth Rate in Pharma Contract Service Business (2020-2025)

Figure 53. Labcorp Drug Development Revenue Growth Rate in Pharma Contract Service Business (2020-2025)

Figure 54. Syneos Health Revenue Growth Rate in Pharma Contract Service Business (2020-2025)

Figure 55. Parexel Revenue Growth Rate in Pharma Contract Service Business (2020-2025)

Figure 56. Medpace Revenue Growth Rate in Pharma Contract Service Business (2020-2025)

Figure 57. Charles River Revenue Growth Rate in Pharma Contract Service Business (2020-2025)

Figure 58. Lonza Revenue Growth Rate in Pharma Contract Service Business (2020-2025)

Figure 59. Aldevron Revenue Growth Rate in Pharma Contract Service Business (2020-2025)

Figure 60. Catalent Revenue Growth Rate in Pharma Contract Service Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Pharma Contract Service in 2031? zhanKai

The global market size of Pharma Contract Service in 2031 was 246380 Million USD.

What is the annual compound growth rate of the global Pharma Contract Service market size from 2025 to 2031? shouQi

Which region is expected to have the highest market share? shouQi

Which companies rank high in the global Pharma Contract Service market? shouQi

What was the global market size of Pharma Contract Service in 2025? shouQi

Related Reports

Pharma Contract Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharma Contract Service was estimated to be worth US$ 161440 million in 2025 and is projected to reach US$ 262570 million, growing at a CAGR of 7.3% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 114
USD 3950.00
(Single User License)
Global Pharma Contract Service Market Research Report 2026
The global Pharma Contract Service market was valued at US$ 161440 million in 2025 and is anticipated to reach US$ 262570 million by 2032, at a CAGR of 7.3% from 2026 to 2032.
Published Date: 2026-04-19
Pages: 120
USD 2900.00
(Single User License)
Global Pharma Contract Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharma Contract Service market size was US$ 151490 million in 2024 and is forecast to a readjusted size of US$ 246380 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published Date: 2025-11-17
Pages: 91
USD 4250.00
(Single User License)
Global Pharma Contract Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharma Contract Service market is projected to grow from US$ 151490 million in 2024 to US$ 246380 million by 2031, at a CAGR of 7.3% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-11-16
Pages: 140
USD 4900.00
(Single User License)
Pharma Contract Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharma Contract Service was estimated to be worth US$ 151490 million in 2024 and is forecast to a readjusted size of US$ 246380 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published Date: 2025-02-04
Pages: 112
USD 3950.00
(Single User License)

Pharma Contract Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharma Contract Service was estimated to be worth US$ 161440 million in 2025 and is projected to reach US$ 262570 million, growing at a CAGR of 7.3% from 2026 to 2032.
Published: 2026-06-16
Pages: 114
USD 3950.00 (Single User License)
Global Pharma Contract Service Market Research Report 2026
The global Pharma Contract Service market was valued at US$ 161440 million in 2025 and is anticipated to reach US$ 262570 million by 2032, at a CAGR of 7.3% from 2026 to 2032.
Published: 2026-04-19
Pages: 120
USD 2900.00 (Single User License)
Global Pharma Contract Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharma Contract Service market size was US$ 151490 million in 2024 and is forecast to a readjusted size of US$ 246380 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published: 2025-11-17
Pages: 91
USD 4250.00 (Single User License)
Global Pharma Contract Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharma Contract Service market is projected to grow from US$ 151490 million in 2024 to US$ 246380 million by 2031, at a CAGR of 7.3% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-16
Pages: 140
USD 4900.00 (Single User License)
Pharma Contract Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharma Contract Service was estimated to be worth US$ 151490 million in 2024 and is forecast to a readjusted size of US$ 246380 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published: 2025-02-04
Pages: 112
USD 3950.00 (Single User License)